133 related articles for article (PubMed ID: 12034449)
1. In vitro folding, functional characterization, and disulfide pattern of the extracellular domain of human GLP-1 receptor.
Bazarsuren A; Grauschopf U; Wozny M; Reusch D; Hoffmann E; Schaefer W; Panzner S; Rudolph R
Biophys Chem; 2002 May; 96(2-3):305-18. PubMed ID: 12034449
[TBL] [Abstract][Full Text] [Related]
2. The isolated N-terminal domain of the glucagon-like peptide-1 (GLP-1) receptor binds exendin peptides with much higher affinity than GLP-1.
López de Maturana R; Willshaw A; Kuntzsch A; Rudolph R; Donnelly D
J Biol Chem; 2003 Mar; 278(12):10195-200. PubMed ID: 12524435
[TBL] [Abstract][Full Text] [Related]
3. The isolated N-terminal extracellular domain of the glucagon-like peptide-1 (GLP)-1 receptor has intrinsic binding activity.
Wilmen A; Göke B; Göke R
FEBS Lett; 1996 Nov; 398(1):43-7. PubMed ID: 8946950
[TBL] [Abstract][Full Text] [Related]
4. The N-terminal fragment of human parathyroid hormone receptor 1 constitutes a hormone binding domain and reveals a distinct disulfide pattern.
Grauschopf U; Lilie H; Honold K; Wozny M; Reusch D; Esswein A; Schäfer W; Rücknagel KP; Rudolph R
Biochemistry; 2000 Aug; 39(30):8878-87. PubMed ID: 10913300
[TBL] [Abstract][Full Text] [Related]
5. A model for receptor-peptide binding at the glucagon-like peptide-1 (GLP-1) receptor through the analysis of truncated ligands and receptors.
Al-Sabah S; Donnelly D
Br J Pharmacol; 2003 Sep; 140(2):339-46. PubMed ID: 12970080
[TBL] [Abstract][Full Text] [Related]
6. The amino terminal domain of the glucagon-like peptide-1 receptor is a critical determinant of subtype specificity.
Graziano MP; Hey PJ; Strader CD
Recept Channels; 1996; 4(1):9-17. PubMed ID: 8723643
[TBL] [Abstract][Full Text] [Related]
7. Expression, purification and preliminary characterization of glucagon receptor extracellular domain.
Wu L; Zhai Y; Lu J; Wang Q; Sun F
Protein Expr Purif; 2013 Jun; 89(2):232-40. PubMed ID: 23597780
[TBL] [Abstract][Full Text] [Related]
8. Exchange of W39 by A within the N-terminal extracellular domain of the GLP-1 receptor results in a loss of receptor function.
Van Eyll B; Göke B; Wilmen A; Göke R
Peptides; 1996; 17(4):565-70. PubMed ID: 8804062
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of glucagon-like peptide-1 in complex with the extracellular domain of the glucagon-like peptide-1 receptor.
Underwood CR; Garibay P; Knudsen LB; Hastrup S; Peters GH; Rudolph R; Reedtz-Runge S
J Biol Chem; 2010 Jan; 285(1):723-30. PubMed ID: 19861722
[TBL] [Abstract][Full Text] [Related]
10. Glucagon-induced self-association of recombinant proteins in Escherichia coli and affinity purification using a fragment of glucagon receptor.
Kim DY; Lee J; Saraswat V; Park YH
Biotechnol Bioeng; 2000 Aug; 69(4):418-28. PubMed ID: 10862680
[TBL] [Abstract][Full Text] [Related]
11. Recombinant expression, in vitro refolding, and biophysical characterization of the human glucagon-like peptide-1 receptor.
Schröder-Tittmann K; Bosse-Doenecke E; Reedtz-Runge S; Ihling C; Sinz A; Tittmann K; Rudolph R
Biochemistry; 2010 Sep; 49(36):7956-65. PubMed ID: 20690636
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity studies of glucagon-like peptide-1.
Adelhorst K; Hedegaard BB; Knudsen LB; Kirk O
J Biol Chem; 1994 Mar; 269(9):6275-8. PubMed ID: 8119974
[TBL] [Abstract][Full Text] [Related]
13. Glucagon-like peptide-1 binding to rat skeletal muscle.
Delgado E; Luque MA; Alcántara A; Trapote MA; Clemente F; Galera C; Valverde I; Villanueva-Peñacarrillo ML
Peptides; 1995; 16(2):225-9. PubMed ID: 7784253
[TBL] [Abstract][Full Text] [Related]
14. Localization of the domains involved in ligand binding and activation of the glucose-dependent insulinotropic polypeptide receptor.
Gelling RW; Wheeler MB; Xue J; Gyomorey S; Nian C; Pederson RA; McIntosh CH
Endocrinology; 1997 Jun; 138(6):2640-3. PubMed ID: 9165060
[TBL] [Abstract][Full Text] [Related]
15. Biological activities of glucagon-like peptide-1 analogues in vitro and in vivo.
Xiao Q; Giguere J; Parisien M; Jeng W; St-Pierre SA; Brubaker PL; Wheeler MB
Biochemistry; 2001 Mar; 40(9):2860-9. PubMed ID: 11258897
[TBL] [Abstract][Full Text] [Related]
16. The glucagon-like peptide-1 receptor binding site for the N-terminus of GLP-1 requires polarity at Asp198 rather than negative charge.
López de Maturana R; Donnelly D
FEBS Lett; 2002 Oct; 530(1-3):244-8. PubMed ID: 12387900
[TBL] [Abstract][Full Text] [Related]
17. Functional coupling of Cys-226 and Cys-296 in the glucagon-like peptide-1 (GLP-1) receptor indicates a disulfide bond that is close to the activation pocket.
Mann RJ; Al-Sabah S; de Maturana RL; Sinfield JK; Donnelly D
Peptides; 2010 Dec; 31(12):2289-93. PubMed ID: 20869417
[TBL] [Abstract][Full Text] [Related]
18. Dipeptidyl peptidase IV resistant analogues of glucagon-like peptide-1 which have extended metabolic stability and improved biological activity.
Deacon CF; Knudsen LB; Madsen K; Wiberg FC; Jacobsen O; Holst JJ
Diabetologia; 1998 Mar; 41(3):271-8. PubMed ID: 9541166
[TBL] [Abstract][Full Text] [Related]
19. Glucagon and glucagon-like peptide 1: selective receptor recognition via distinct peptide epitopes.
Hjorth SA; Adelhorst K; Pedersen BB; Kirk O; Schwartz TW
J Biol Chem; 1994 Dec; 269(48):30121-4. PubMed ID: 7527026
[TBL] [Abstract][Full Text] [Related]
20. Glucagon and GLP-1 receptors: lessons from chimeric ligands and receptors.
Hjorth SA; Schwartz TW
Acta Physiol Scand; 1996 Jul; 157(3):343-5. PubMed ID: 8830889
[No Abstract] [Full Text] [Related]
[Next] [New Search]
